1. Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021
- Author
-
Jessica Justman, Timothy Skalland, Ayana Moore, Christopher I. Amos, Mark A. Marzinke, Sahar Z. Zangeneh, Colleen F. Kelley, Rebecca Singer, Stockton Mayer, Yael Hirsch-Moverman, Susanne Doblecki-Lewis, David Metzger, Elizabeth Barranco, Ken Ho, Ernesto T.A. Marques, Margaret Powers-Fletcher, Patricia J. Kissinger, Jason E. Farley, Carrie Knowlton, Magdalena E. Sobieszczyk, Shobha Swaminathan, Domonique Reed, Jean De Dieu Tapsoba, Lynda Emel, Ian Bell, Krista Yuhas, Leah Schrumpf, Laura Mkumba, Jontraye Davis, Jonathan Lucas, Estelle Piwowar-Manning, and Shahnaz Ahmed
- Subjects
COVID-19 ,2019 novel coronavirus disease ,coronavirus disease ,severe acute respiratory syndrome coronavirus 2 ,SARS-CoV-2 ,viruses ,Medicine ,Infectious and parasitic diseases ,RC109-216 - Abstract
During January–August 2021, the Community Prevalence of SARS-CoV-2 Study used time/location sampling to recruit a cross-sectional, population-based cohort to estimate SARS-CoV-2 seroprevalence and nasal swab sample PCR positivity across 15 US communities. Survey-weighted estimates of SARS-CoV-2 infection and vaccine willingness among participants at each site were compared within demographic groups by using linear regression models with inverse variance weighting. Among 22,284 persons >2 months of age and older, median prevalence of infection (prior, active, or both) was 12.9% across sites and similar across age groups. Within each site, average prevalence of infection was 3 percentage points higher for Black than White persons and average vaccine willingness was 10 percentage points lower for Black than White persons and 7 percentage points lower for Black persons than for persons in other racial groups. The higher prevalence of SARS-CoV-2 infection among groups with lower vaccine willingness highlights the disparate effect of COVID-19 and its complications.
- Published
- 2024
- Full Text
- View/download PDF